Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
Puntos clave
The study aims to evaluate the use of complement-binding capacity of donor-specific anti-HLA antibodies for risk assessment of kidney-allograft loss.
Assessed the complement-binding capacity of donor-specific anti-HLA antibodies in patients.
Identified high-risk patients based on antibody profiles.
Patients identified with high complement-binding antibodies showed increased risk for kidney-allograft loss.
Resumen
Assessment of the complement-binding capacity of donor-specific anti-HLA antibodies appears to be useful in identifying patients at high risk for kidney-allograft loss.